Aeterna Zentaris General and Administrative Expenses 2011-2026 | AEZS

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Aeterna Zentaris

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	5.92 M	4.76 M	6.62 M	8.89 M	8.2 M	7.15 M	4.68 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
8.89 M	4.68 M	6.6 M

Quarterly General and Administrative Expenses Aeterna Zentaris

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	1.56 M	-	1.23 M	1.64 M	1.26 M	-	1.18 M	1.14 M	1.12 M	-	1.36 M	1.92 M	1.64 M	-	2.44 M	2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.44 M	1.12 M	1.54 M

General and Administrative Expenses of other stocks in the Biotechnology industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	78.3 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	12.7 M	-	2.71 %	$ 14 M	USA
AbbVie ABBV	14 B	$ 232.08	3.29 %	$ 411 B	USA
AbCellera Biologics ABCL	83.2 M	$ 3.61	0.56 %	$ 1.08 B	Canada
Abeona Therapeutics ABEO	19 M	$ 5.12	-1.54 %	$ 109 M	USA
Arbutus Biopharma Corporation ABUS	22.5 M	$ 4.66	-0.85 %	$ 773 M	Canada
ACADIA Pharmaceuticals ACAD	488 M	$ 24.56	-0.32 %	$ 4.07 B	USA
I-Mab IMAB	900 M	-	-	$ 866 M	China
Achieve Life Sciences ACHV	11.4 M	$ 4.56	-3.59 %	$ 90.4 M	USA
AC Immune SA ACIU	17.9 M	$ 2.93	-1.01 %	$ 229 M	Schweiz
Alexion Pharmaceuticals, Inc. ALXN	1.4 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	9.33 M	-	-10.17 %	$ 12.2 K	USA
Aclaris Therapeutics ACRS	22 M	$ 2.87	-8.31 %	$ 352 M	USA
Biophytis SA BPTS	7.15 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	47.9 M	-	-	$ 1.01 B	USA
Adagene ADAG	14.4 M	$ 2.96	-4.67 %	$ 167 M	China
ADC Therapeutics SA ADCT	71.5 M	$ 4.1	-0.73 %	$ 105 M	Schweiz
Adial Pharmaceuticals ADIL	5.06 M	$ 2.53	-	$ 16.4 M	USA
ADMA Biologics ADMA	91.6 M	$ 15.57	2.57 %	$ 3.71 B	USA
Applied Genetic Technologies Corporation AGTC	17 M	-	-	$ 26.5 M	USA
Adaptive Biotechnologies Corporation ADPT	72.7 M	$ 16.02	-2.67 %	$ 2.43 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	4.66 M	-	-1.52 %	$ 24.7 M	USA
ADiTx Therapeutics ADTX	16.3 M	$ 0.46	-4.63 %	$ 6.06 K	USA
Midatech Pharma plc MTP	4.95 M	-	-18.52 %	$ 27.3 M	Britain
Agenus AGEN	78.7 M	$ 3.33	-0.89 %	$ 1.19 M	USA
Agios Pharmaceuticals AGIO	180 M	$ 30.23	0.83 %	$ 1.75 B	USA
AIM ImmunoTech AIM	13.1 M	$ 0.91	-8.59 %	$ 43.8 M	USA
Akebia Therapeutics AKBA	107 M	$ 1.31	-0.76 %	$ 337 M	USA
Akari Therapeutics, Plc AKTX	9.66 M	$ 0.24	-8.87 %	$ 5.73 B	Britain
ARCA biopharma ABIO	13.1 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	89.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7.17 M	-	4.01 %	$ 150 M	Canada
Aldeyra Therapeutics ALDX	9.6 M	$ 5.46	-0.73 %	$ 328 M	USA
Alector ALEC	54 M	$ 2.43	-5.08 %	$ 250 M	USA
Aligos Therapeutics ALGS	30.6 M	$ 7.03	-6.27 %	$ 452 M	USA
Adverum Biotechnologies ADVM	63.1 M	-	-	$ 86.2 M	USA
Alkermes plc ALKS	222 M	$ 30.1	-2.05 %	$ 4.96 B	Irlanda
Институт стволовых клеток человека ISKJ	25.8 M	-	-	-	Russia
Allogene Therapeutics ALLO	71.7 M	$ 2.78	1.83 %	$ 436 M	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Alnylam Pharmaceuticals ALNY	1.21 B	$ 332.92	0.51 %	$ 43.6 B	USA
Akero Therapeutics AKRO	37.9 M	-	-	$ 3.67 B	USA
Akouos AKUS	22.2 M	-	0.23 %	$ 488 M	USA
Altimmune ALT	21 M	$ 4.31	-3.36 %	$ 306 M	USA
Albireo Pharma ALBO	69.6 M	-	-0.23 %	$ 916 M	USA
ALX Oncology Holdings ALXO	26.1 M	$ 2.11	-10.21 %	$ 110 M	USA
Allena Pharmaceuticals ALNA	12.7 M	-	3.16 %	$ 1.9 M	USA
Amgen AMGN	7.05 B	$ 388.16	2.33 %	$ 209 B	USA
Aileron Therapeutics ALRN	13.9 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	42.9 M	-	4.14 %	$ 49.1 M	USA